These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 3681663

  • 1. [Effects of beta- and dimethyl beta-cyclodextrins on release and percutaneous absorption behaviors of prednisolone from some ointment bases].
    Uekama K, Masaki K, Arimori K, Irie T, Hirayama F.
    Yakugaku Zasshi; 1987 Jun; 107(6):449-56. PubMed ID: 3681663
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits.
    Arimori K, Uekama K.
    J Pharmacobiodyn; 1987 Aug; 10(8):390-5. PubMed ID: 3694434
    [Abstract] [Full Text] [Related]

  • 4. Improvement in the percutaneous absorption of beclomethasone dipropionate by gamma-cyclodextrin complexation.
    Uekama K, Otagiri M, Sakai A, Irie T, Matsuo N, Matsuoka Y.
    J Pharm Pharmacol; 1985 Aug; 37(8):532-5. PubMed ID: 2864411
    [Abstract] [Full Text] [Related]

  • 5. Improvement of oral bioavailability of prednisolone by beta-cyclodextrin complexation in humans.
    Uekama K, Otagiri M, Uemura Y, Fujinaga T, Arimori K, Matsuo N, Tasaki K, Sugii A.
    J Pharmacobiodyn; 1983 Feb; 6(2):124-7. PubMed ID: 6864436
    [Abstract] [Full Text] [Related]

  • 6. [Effect of dimethyl beta-cyclodextrin on oral or rectal absorption of 1-hexylcarbamoyl-5-fluorouracil (HCFU)].
    Kikuchi M, Uekama K.
    Yakugaku Zasshi; 1988 Feb; 108(2):156-63. PubMed ID: 3404404
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of interfacial transfer and absorption behavior of drugs following dissolution from beta-cyclodextrin complexes.
    Uekama K, Uemura Y, Irie T, Otagiri M.
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3637-43. PubMed ID: 6671224
    [No Abstract] [Full Text] [Related]

  • 8. Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.
    Hermens WA, Deurloo MJ, Romeyn SG, Verhoef JC, Merkus FW.
    Pharm Res; 1990 May; 7(5):500-3. PubMed ID: 2367318
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
    Seo H, Tsuruoka M, Hashimoto T, Fujinaga T, Otagiri M, Uekama K.
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):286-91. PubMed ID: 6850944
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M, Antal A.
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of pharmacological activity of CERM 3726 with a ground mixture of beta-cyclodextrin in mice.
    Luu SN, Chaperon F, Leinot M, Pourrat A.
    Pharm Acta Helv; 1987 Dec; 62(12):335-6. PubMed ID: 3441478
    [No Abstract] [Full Text] [Related]

  • 13. Effect of beta-cyclodextrin on sleeping time induced by barbituric acid derivatives in mice.
    Shirakura O, Nambu N, Nagai T.
    Chem Pharm Bull (Tokyo); 1985 Aug; 33(8):3517-21. PubMed ID: 4085080
    [No Abstract] [Full Text] [Related]

  • 14. Reduction in the local tissue toxicity of chlorpromazine by beta-cyclodextrin complexation.
    Irie T, Kuwahara S, Otagiri M, Uekama K, Iwamasa T.
    J Pharmacobiodyn; 1983 Oct; 6(10):790-2. PubMed ID: 6663444
    [Abstract] [Full Text] [Related]

  • 15. Interaction of tri-O-methyl-beta-cyclodextrin with drugs. II. Enhanced bioavailability of ketoprofen in rats when administered with tri-O-methyl-beta-cyclodextrin.
    Nakai Y, Yamamoto K, Terada K, Horibe H, Ozawa K.
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3745-7. PubMed ID: 6671012
    [No Abstract] [Full Text] [Related]

  • 16. [Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation (author's transl)].
    Uekama K, Matsuo N, Hirayama F, Ichibagase H, Arimori K, Tsubaki K, Satake K.
    Yakugaku Zasshi; 1980 Sep; 100(9):903-9. PubMed ID: 7218151
    [No Abstract] [Full Text] [Related]

  • 17. Inactivation of sarin and soman by cyclodextrins in vitro.
    Désiré B, Saint-André S.
    Experientia; 1987 Apr 15; 43(4):395-7. PubMed ID: 3569488
    [Abstract] [Full Text] [Related]

  • 18. [Prostaglandins in the rat gastric mucosa (10th report). Effect of beta-cyclodextrin clathrate of 2-benzyloxycarbonylphenyl trans-4-guanidinomethylcyclohexanecarboxylate hydrocholine (TA903) on mucosal prostaglandins].
    Arakawa T, Nakamura H, Satoh H, Chono S, Yamada H, Fukuda T, Higuchi K, Ono T, Kobayashi K.
    Nihon Shokakibyo Gakkai Zasshi; 1984 Jul 15; 81(7):1554-8. PubMed ID: 6387227
    [No Abstract] [Full Text] [Related]

  • 19. Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I.
    Imaizumi A, Suzuki Y, Ono S, Sato H, Sato Y.
    J Clin Microbiol; 1983 May 15; 17(5):781-6. PubMed ID: 6306047
    [Abstract] [Full Text] [Related]

  • 20. Effects of beta- and gamma-cyclodextrins on release of betamethasone from ointment bases.
    Otagiri M, Fujinaga T, Sakai A, Uekama K.
    Chem Pharm Bull (Tokyo); 1984 Jun 15; 32(6):2401-5. PubMed ID: 6488409
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.